Abstract
The development of high-throughput, data-intensive biomedical research assays and technologies has created a need for researchers to develop strategies for analyzing, integrating, and interpreting the massive amounts of data they generate. Although a wide variety of statistical methods have been designed to accommodate ‘big data,’ experiences with the use of artificial intelligence (AI) techniques suggest that they might be particularly appropriate. In addition, the results of the application of these assays reveal a great heterogeneity in the pathophysiologic factors and processes that contribute to disease, suggesting that there is a need to tailor, or ‘personalize,’ medicines to the nuanced and often unique features possessed by individual patients. Given how important data-intensive assays are to revealing appropriate intervention targets and strategies for treating an individual with a disease, AI can play an important role in the development of personalized medicines. We describe many areas where AI can play such a role and argue that AI’s ability to advance personalized medicine will depend critically on not only the refinement of relevant assays, but also on ways of storing, aggregating, accessing, and ultimately integrating, the data they produce. We also point out the limitations of many AI techniques in developing personalized medicines as well as consider areas for further research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Russell S, Norvig P (2009) Artificial intelligence: a modern approach, 3rd edn. Pearson, Carmel, IN
Mahmud M et al (2018) Applications of deep learning and reinforcement learning to biological data. IEEE Trans Neural Netw Learn Syst 29(6):2063–2079
Webb S (2018) Deep learning for biology. Nature 554(7693):555–557
Fleming N (2018) How artificial intelligence is changing drug discovery. Nature 557(7707):S55–S57
Committee to Review the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences, Board on Health Sciences Policy, Institute of Medicine, Leshner AI, Terry S (eds) (2013) The CTSA program at NIH: opportunities for advancing clinical and translational research. The national academies collection: reports funded by National Institutes of Health. National Academies Press, Washington, DC
Schork NJ, Nazor K (2017) Integrated genomic medicine: a paradigm for rare diseases and beyond. Adv Genet 97:81–113
Telenti A et al (2018) Deep learning of genomic variation and regulatory network data. Hum Mol Genet 27(R1):R63–R71
Esteva A et al (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542(7639):115–118
Gerstung M et al (2017) Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nat Genet 49(3):332–340
Gulshan V et al (2016) Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316(22):2402–2410
Cohen JD et al (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359(6378):926–930
Bray MA et al (2017) A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay. Gigascience 6(12):1–5
Ma J et al (2018) Using deep learning to model the hierarchical structure and function of a cell. Nat Methods 15(4):290–298
Ideker T et al (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292(5518):929–934
Bohannon J (2017) The cyberscientist. Science 357(6346):18–21
King RD et al (2009) The automation of science. Science 324(5923):85–89
Sparkes A, Clare A (2012) AutoLabDB: a substantial open source database schema to support a high-throughput automated laboratory. Bioinformatics 28(10):1390–1397
Butler KT et al (2018) Machine learning for molecular and materials science. Nature 559(7715):547–555
Sanchez-Lengeling B, Aspuru-Guzik A (2018) Inverse molecular design using machine learning: generative models for matter engineering. Science 361(6400):360–365
Aage N et al (2017) Giga-voxel computational morphogenesis for structural design. Nature 550(7674):84–86
Segler MHS, Preuss M, Waller MP (2018) Planning chemical syntheses with deep neural networks and symbolic AI. Nature 555(7698):604–610
Ahneman DT et al (2018) Predicting reaction performance in C-N cross-coupling using machine learning. Science 360(6385):186–190
Radovic A et al (2018) Machine learning at the energy and intensity frontiers of particle physics. Nature 560(7716):41–48
Silver D et al (2017) Mastering the game of Go without human knowledge. Nature 550(7676):354–359
Madhukar NS et al (2018) A new big-data paradigm for target identification and drug discovery. BioRxiv. https://doi.org/10.1101/134973
Chen B, Butte AJ (2016) Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther 99(3):285–297
Hu Y, Bajorath J (2017) Entering the ‘big data’ era in medicinal chemistry: molecular promiscuity analysis revisited. Future Sci OA 3(2):FSO179
Hernandez D (2018) How robots are making better drugs, faster. In: Wall Street Journal. Dow Jones & Company, New York, NY
Patient-centered drug manufacture (2017) Nat Biotechnol 35(6):485
Schellekens H et al (2017) Making individualized drugs a reality. Nat Biotechnol 35(6):507–513
Lavertu A et al (2018) Pharmacogenomics and big genomic data: from lab to clinic and back again. Hum Mol Genet 27(R1):R72–R78
Kalinin AA et al (2018) Deep learning in pharmacogenomics: from gene regulation to patient stratification. Pharmacogenomics 19(7):629–650
Schork NJ (2015) Personalized medicine: time for one-person trials. Nature 520(7549):609–611
Serhani MA et al (2017) New algorithms for processing time-series big EEG data within mobile health monitoring systems. Comput Methods Programs Biomed 149:79–94
Marr B (2017) First FDA approval for clinical cloud-based deep learning in healthcare. In: Forbes. Forbes Publishing Company, New York City
Miotto R et al (2016) Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci Rep 6:26094
Rossi G, Manfrin A, Lutolf MP (2018) Progress and potential in organoid research. Nat Rev Genet
Deng Y et al (2018) Massive single-cell RNA-seq analysis and imputation via deep learning. BioRxiv. https://t.co/EGBwlYFLLK
Yauney G, Shah P (2018) Reinforcement learning with action-derived rewards for chemotherapy and clinical trial dosing regimen selection. In: Proceedings of machine learning research, vol 85
Biankin AV, Piantadosi S, Hollingsworth SJ (2015) Patient-centric trials for therapeutic development in precision oncology. Nature 526(7573):361–370
Kodack DP et al (2017) Primary patient-derived cancer cells and their potential for personalized cancer patient care. Cell Rep 21(11):3298–3309
Gorshkov K et al (2018) Advancing precision medicine with personalized drug screening. Drug Discov Today
Miranda CC et al (2018) Towards multi-organoid systems for drug screening applications. Bioengineering (Basel) 5(3)
Scott IA et al (2018) Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Ther Adv Drug Saf 9(9):559–573
Dreyer KJ, Geis JR (2017) When machines think: radiology’s next frontier. Radiology 285(3):713–718
Nabi J (2018) How bioethics can shape artificial intelligence and machine learning. Hastings Cent Rep 48(5):10–13
Etheredge LM (2007) A rapid-learning health system. Health Aff (Millwood) 26(2):w107–w118
Shrager J, Tenenbaum JM (2014) Rapid learning for precision oncology. Nat Rev Clin Oncol 11(2):109–118
Shah A et al (2016) Building a rapid learning health care system for oncology: why CancerLinQ collects identifiable health information to achieve its vision. J Clin Oncol 34(7):756–763
Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning: data mining, inference, and prediction, 2nd edn. Springer, New York
Schork NJ, Goetz LH (2017) Single-subject studies in translational nutrition research. Annu Rev Nutr 37:395–422
Agarwala V et al (2018) Real-world evidence in support of precision medicine: clinico-genomic cancer data as a case study. Health Aff (Millwood) 37(5):765–772
Williams MS et al (2018) Patient-centered precision health in a learning health care system: Geisinger’s genomic medicine experience. Health Aff (Millwood) 37(5):757–764
Rajkomar A et al (2018) Scalable and accurate deep learning with electronic health records. NPJ Digit Med 1(18)
Ali M, Aittokallio T (2018) Machine learning and feature selection for drug response prediction in precision oncology applications. Biophys Rev
Mathe E et al (2018) The omics revolution continues: the maturation of high-throughput biological data sources. Yearb Med Inform 27(1):211–222
Varghese J et al (2018) CDEGenerator: an online platform to learn from existing data models to build model registries. Clin Epidemiol 10:961–970
Lerner I et al (2018) Revolution in health care: how will data science impact doctor-patient relationships? Front Public Health 6:99
Savage N (2017) Machine learning: calculating disease. Nature 550(7676):S115–S117
Bycroft C et al (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562:203–209
Sankar PL, Parker LS (2017) The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med 19(7):743–750
Li C et al (2018) Application of induced pluripotent stem cell transplants: autologous or allogeneic? Life Sci
Graham C et al (2018) Allogeneic CAR-T cells: more than ease of access? Cells 7(10)
Tan R, Yang X, Shen Y (2017) Robot-aided electrospinning toward intelligent biomedical engineering. Robotics Biomim 4(1):17
Osouli-Bostanabad K, Adibkia K (2018) Made-on-demand, complex and personalized 3D-printed drug products. Bioimpacts 8(2):77–79
Schork NJ (2018) Randomized clinical trials and personalized medicine: a commentary on deaton and cartwright. Soc Sci Med 210:71–73
Shamsuddin R et al (2018) Virtual patient model: an approach for generating synthetic healthcare time series data. In: IEEE international conference on healthcare informatics. IEEE Computer Society
Fisher AJ, Medaglia JD, Jeronimus BF (2018) Lack of group-to-individual generalizability is a threat to human subjects research. Proc Natl Acad Sci U S A 115(27):E6106–E6115
Drescher CW et al (2013) Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. J Clin Oncol 31(3):387–392
Zhou N et al (2018) Concordance study between IBM Watson for Oncology and clinical practice for patients with cancer in China. Oncologist
Schmidt C (2017) M. D. Anderson breaks with IBM Watson, raising questions about artificial intelligence in oncology. J Natl Cancer Inst 109(5):4–5
Abramoff MD et al (2018) Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 1(39)
Lazer D et al (2014) Big data. The parable of Google Flu: traps in big data analysis. Science 343(6176):1203–1205
Le Tourneau C et al (2015) Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 16(13):1324–1334
Ioannidis JPA, Khoury MJ (2018) Evidence-based medicine and big genomic data. Hum Mol Genet 27(R1):R2–R7
AI diagnostics need attention (2018) Nature 555(7696):285
Frieden TR (2017) Evidence for health decision making—beyond randomized, controlled trials. N Engl J Med 377(5):465–475
Abernethy A, Khozin S (2017) Clinical drug trials may be coming to your doctor’s office. In: Wall Street Journal. Dow Jones & Company, New York, NY
Voosen P (2017) The AI detectives. Science 357(6346):22–27
Marwala T (2015) Causality, correlation and artificial intelligence for rational decision making. World Scientific, New Jersey
Ciliberto C et al (2018) Quantum machine learning: a classical perspective. Proc Math Phys Eng Sci 474(2209):20170551
Li RY et al (2018) Quantum annealing versus classical machine learning applied to a simplified computational biology problem. npj Quantum Inf 4
Vashistha R et al (2018) Futuristic biosensors for cardiac health care: an artificial intelligence approach. 3 Biotech 8(8):358
Palsson B (2015) Systems biology: constraint-based reconstruction and analysis, 2nd edn. Cambridge University Press, Boston, MA
Ideker T, Dutkowski J, Hood L (2011) Boosting signal-to-noise in complex biology: prior knowledge is power. Cell 144(6):860–863
Khera AV et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50(9):1219–1224
Warren M (2018) The approach to predictive medicine that is taking genomics research by storm. Nature 562(7726):181–183
Schork AJ, Schork MA, Schork NJ (2018) Genetic risks and clinical rewards. Nat Genet 50(9):1210–1211
Patel CJ et al (2013) Whole genome sequencing in support of wellness and health maintenance. Genome Med 5(6):58
Schork NJ (2013) Genetic parts to a preventive medicine whole. Genome Med 5(6):54
Mapara SS, Patravale VB (2017) Medical capsule robots: a renaissance for diagnostics, drug delivery and surgical treatment. J Control Release 261:337–351
Topol EJ (2019) Deep medicine: how artificial intelligence can make healthcare human again. Basic Books, New York
David LA et al (2014) Host lifestyle affects human microbiota on daily timescales. Genome Biol 15(7):R89
Chen R et al (2012) Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6):1293–1307
Magnuson V, Wang Y, Schork N (2016) Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT). F1000Research 5:132
Zeevi D et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163(5):1079–1094
Smarr L et al (2017) Tracking human gut microbiome changes resulting from a colonoscopy. Methods Inf Med 56(6):442–447
Trammell SA et al (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948
Forsdyke DR (2015) Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker. BMC Res Notes 8:227
O’Rawe JA et al (2013) Integrating precision medicine in the study and clinical treatment of a severely mentally ill person. PeerJ 1:e177
Li W et al (2016) Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci U S A 113(23):6544–6549
Bloss CS et al (2015) A genome sequencing program for novel undiagnosed diseases. Genet Med 17(12):995–1001
Piening BD et al (2018) Integrative personal omics profiles during periods of weight gain and loss. Cell Syst 6(2):157–170 e8
Zalusky R, Herbert V (1961) Megaloblastic anemia in scurvy with response to 50 microgm. of folic acid daily. N Engl J Med 265:1033–1038
Herbert V (1962) Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 75:307–320
Golding PH (2014) Severe experimental folate deficiency in a human subject—a longitudinal study of biochemical and haematological responses as megaloblastic anaemia develops. Springerplus 3:442
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schork, N.J. (2019). Artificial Intelligence and Personalized Medicine. In: Von Hoff, D., Han, H. (eds) Precision Medicine in Cancer Therapy . Cancer Treatment and Research, vol 178. Springer, Cham. https://doi.org/10.1007/978-3-030-16391-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-16391-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16390-7
Online ISBN: 978-3-030-16391-4
eBook Packages: MedicineMedicine (R0)